REGISTERED CHARITY NUMBER: 1101433
Report of the Trustees and
Financial Statements for the Year Ended 31 October 2020
for
EPSOM MEDICAL RESEARCH
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
EPSOM MEDICAL RESEARCH
Contents of the Financial Statements
for the Year Ended 31 October 2020
|
Page |
Report of the Trustees |
1 to 2 |
Independent Examiner's Report |
3 |
Statement of Financial Activities |
4 |
Balance Sheet |
5 |
Notes to the Financial Statements |
6 to 9 |
Detailed Statement of Financial Activities |
10 |
EPSOM MEDICAL RESEARCH
Report of the Trustees
for the Year Ended 31 October 2020
Thetrusteespresenttheirreportwiththefinancialstatementsofthecharityfortheyear ended
31October2020.ThetrusteeshaveadoptedtheprovisionsoftheStatementofRecommended Practice
(SORP) 'Accounting and Reporting by Charities' issued in March 2005.
REFERENCE AND ADMINISTRATIVE DETAILS Registered Charity number
1101433
Principal address
85 Rydens Road
Elmbridge
Walton-on-Thames
Surrey
KT12 3AN
Trustees
Dr. L G Darlington
Ms S Kumar
K W D Ramsey
Independent examiner
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
Thecharityiscontrolledbyitsgoverningdocument,adeedoftrust,andconstitutesan unincorporated
charity.
Risk management
Thetrusteeshaveadutytoidentifyandreviewtheriskstowhichthecharityisexposedandto ensure
appropriate controls are in place to provide reasonable assurance against fraud and error.
OBJECTIVES AND ACTIVITIES
Objectives and aims
TheobjectivesoftheEpsomMedicalResearchareinthefieldofresearchwithintheareas of
rheumatology, general medicine, inflammation, neuroscience and cancer.
ACHIEVEMENT AND PERFORMANCE
Charitable activities in the year
The Charity supported research into the areas defined in its objectives during the year.
Page 1
EPSOM MEDICAL RESEARCH
Report of the Trustees
for the Year Ended 31 October 2020
Approved by order of the board of trustees on 26 August 2021 and signed on its behalf by:
Dr. L G Darlington - Trustee
Page 2
Independent Examiner's Report to the Trustees of
Epsom Medical Research
I report on the accounts for the year ended 31 October 2020, which are set out on pages four to nine.
Responsibilities and basis of report
Asthecharity'strusteesyouareresponsibleforthepreparationoftheaccountsinaccordancewith the
requirements of the Charities Act 2011 ('the Act').
I haveexaminedyourcharity'saccountsas requiredunder section145of the CharitiesAct 2011('the Act').
IncarryingoutmyexaminationIhavefollowedtheDirectionsgivenbytheCharityCommission under
section 145(5)(b) of the 2011 Act.
My role is to state whether any material matters have come to my attention giving me cause to believe:
1. that accounting records were not kept as required by section 130 of the Act; or
2. that the accounts do not accord with those records; or
3. that the accounts do not comply with the accounting requirements of the Act; or
4. that there is further information needed for a proper understanding of the accounts.
Independent examiner's statement
Ihavecompletedmyexaminationandhavenoconcernsinrespectofthematters(1)to(4)listed above
and,inconnectionwithfollowingtheDirectionsoftheCharityCommissionIhavefoundnomatters that
require drawing to your attention.
Mr Ryan Cottington
FCCA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
26 August 2021
Page 3
EPSOM MEDICAL RESEARCH
Statement of Financial Activities
for the Year Ended 31 October 2020
2020
Unrestricted
fund
Notes
£
INCOMING RESOURCES
Incoming resources from generated funds
Voluntary income
45,395
Investment income
2
-
Total incoming resources
45,395
RESOURCES EXPENDED
Charitable activities
Grants
62,465
Other resources expended
1,682
Total resources expended
64,147
NET INCOMING/(OUTGOING) RESOURCES
(18,752)
RECONCILIATION OF FUNDS
Total funds brought forward
(194,786)
TOTAL FUNDS CARRIED FORWARD
(213,538) |
2019
Total
funds
£
41,035
57
41,092
35,770
1,658
37,428
3,664
(198,450)
(194,786) |
|
|
The notes form part of these financial statements
Page 4
EPSOM MEDICAL RESEARCH
Balance Sheet
At 31 October 2020
2020
Unrestricted
fund
Notes
£
CURRENT ASSETS
Debtors
4
9,288
Cash at bank
10,382
19,670
CREDITORS
Amounts falling due within one year
5
(233,208)
NET CURRENT ASSETS/(LIABILITIES)
(213,538)
TOTAL ASSETS LESS CURRENT LIABILITIES
(213,538)
NET ASSETS/(LIABILITIES)
(213,538)
FUNDS
6
Unrestricted funds
(213,538)
TOTAL FUNDS
(213,538) |
2019
Total
funds
£
209
24,658
24,867
(219,653)
(194,786)
(194,786)
(194,786)
(194,786)
(194,786) |
|
|
ThefinancialstatementswereapprovedbytheBoardofTrusteeson26August2021andweresigned on
its behalf by:
Dr. L G Darlington -Trustee
The notes form part of these financial statements
Page 5
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements
for the Year Ended 31 October 2020
1. ACCOUNTING POLICIES
Accounting convention
Thefinancialstatementshavebeenpreparedunderthehistoricalcostconvention,and in
accordancewiththeFinancialReportingStandardforSmallerEntities(effectiveApril2008), the
CharitiesAct2011andtherequirementsoftheStatementofRecommendedPractice, Accounting
and Reporting by Charities.
Incoming resources
AllincomingresourcesareincludedontheStatementofFinancialActivitieswhenthecharity is
legally entitled to the income and the amount can be quantified with reasonable accuracy.
Resources expended
Expenditureisaccountedforonanaccrualsbasisandhasbeenclassifiedunderheadings that
aggregateallcostrelatedtothecategory.Wherecostscannotbedirectlyattributedto particular
headings they have been allocated to activities on a basis consistent with the use of resources.
Grantsofferedsubjecttoconditionswhichhavenotbeenmetattheyearenddatearenotedas a
commitment but not accrued as expenditure.
Taxation
The charity is exempt from tax on its charitable activities.
Fund accounting
Unrestrictedfundscanbe usedin accordancewiththecharitableobjectivesat thediscretionof the
trustees.
Restrictedfunds can only be used for particularrestrictedpurposeswithin the objectsof the charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
Furtherexplanationofthenatureandpurposeofeachfundis includedin thenotestothe financial
statements.
2. INVESTMENT INCOME
|
2020 |
2019 |
|
£ |
£ |
Deposit account interest |
- |
57 |
Page 6
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements - continued
for the Year Ended 31 October 2020
3. TRUSTEES' REMUNERATION AND BENEFITS
Therewere no trustees'remunerationor otherbenefitsfor the yearended 31 October2020nor for
the year ended 31 October 2019.
Trustees' expenses
Therewerenotrustees'expensespaidfortheyearended31October2020norfortheyear ended
31 October 2019 .
4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
|
|
|
2020 |
2019 |
|
|
|
£ |
£ |
|
Other debtors |
|
9,288 |
209 |
5. |
CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR |
|
|
|
|
|
|
2020 |
2019 |
|
|
|
£ |
£ |
|
Other creditors |
|
208,610 |
208,610 |
|
Accruals and deferred income |
|
24,598 |
11,043 |
|
|
|
233,208 |
219,653 |
6. |
MOVEMENT IN FUNDS |
|
|
|
|
|
|
Net |
|
|
|
|
movement |
|
|
|
At 1/11/19 |
in funds |
At 31/10/20 |
|
|
£ |
£ |
£ |
|
Unrestricted funds |
|
|
|
|
General fund |
(194,786) |
(18,752) |
(213,538) |
|
TOTAL FUNDS |
(194,786) |
(18,752) |
(213,538) |
Page 7
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements - continued for the Year Ended 31 October 2020
6. MOVEMENT IN FUNDS - continued
Net movement in funds, included in the above are as follows:
|
Incoming |
Incoming |
Resources |
Movement |
|
|
resources |
|
expended |
in funds |
|
|
|
£ |
£ |
£ |
|
Unrestricted funds |
|
|
|
|
|
General fund |
|
45,395 |
(64,147) |
(18,752) |
|
TOTAL FUNDS |
|
45,395 |
(64,147) |
(18,752) |
|
Comparatives for movement in funds |
|
|
|
|
|
|
|
|
Net |
|
|
|
|
|
movement |
|
|
|
At 1/11/18 |
|
in funds |
At 31/10/19 |
|
|
|
£ |
£ |
£ |
|
Unrestricted Funds |
|
|
|
|
|
General fund |
(198,450) |
|
3,664 |
(194,786) |
|
TOTAL FUNDS |
(198,450) |
|
3,664 |
(194,786) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Comparative net movement in funds, included in the |
above are as follows: |
|
|
|
|
|
Incoming |
|
Resources |
Movement |
|
|
resources |
|
expended |
in funds |
|
|
|
£ |
£ |
£ |
|
Unrestricted funds |
|
|
|
|
|
General fund |
|
41,092 |
(37,428) |
3,664 |
|
TOTAL FUNDS |
|
41,092 |
(37,428) |
3,664 |
|
|
|
|
|
|
|
Page 8
EPSOM MEDICAL RESEARCH
Notes to the Financial Statements - continued for the Year Ended 31 October 2020
6. MOVEMENT IN FUNDS - continued
A current year 12 months and prior year 12 months combined position is as follows:
|
|
Net |
|
|
|
movement |
|
|
At 1/11/18 |
in funds |
At 31/10/20 |
|
£ |
£ |
£ |
Unrestricted funds |
|
|
|
General fund |
(198,450) |
(15,088) |
(213,538) |
TOTAL FUNDS |
(198,450) |
(15,088) |
(213,538) |
Acurrentyear12monthsandprioryear12monthscombinednetmovementinfunds,included in
the above are as follows:
|
Incoming |
Resources |
Movement |
|
resources |
expended |
in funds |
|
£ |
£ |
£ |
Unrestricted funds |
|
|
|
General fund |
86,487 |
(101,575) |
(15,088) |
TOTAL FUNDS |
86,487 |
(101,575) |
(15,088) |
Page 9
EPSOM MEDICAL RESEARCH
Detailed Statement of Financial Activities
for the Year Ended 31 October 2020
INCOMING RESOURCES
Voluntary income
Donations
Gift aid
Investment income
Deposit account interest
Total incoming resources
RESOURCES EXPENDED
Charitable activities
Research salaries
Research expenses
Support costs
Other 4
Accountancy and legal fees
Total resources expended
Net (expenditure)/income |
2020
£
36,316
9,079
45,395
-
45,395
34,062
28,403
62,465
1,682
64,147
(18,752) |
2019
£
33,141
7,894 |
|
|
41,035
57 |
|
|
41,092
28,470
7,300 |
|
|
35,770
1,658 |
|
|
37,428 |
|
|
3,664 |
This page does not form part of the statutory financial statements
Page 10